Deoxyribonucleoside Toxicity in Adenosine Deaminase and Purine Nucleoside Phosphorylase Deficiency: Implications for the Development of New Immunosuppressive Agents
- 1 January 1979
- book chapter
- Published by Wiley
- No. 68,p. 115-133
- https://doi.org/10.1002/9780470720516.ch8
Abstract
The immunodeficient state associated with adenosine deaminase (ADA) and purine nucleoside phosphorylase (PNP) deficiency may result from the selective phosphorylation by thymus-derived lymphocytes of the ADA substrate deoxyadenosine and the PNP substrate deoxyguanosine, leading to the intracellular trapping of toxic deoxyribonucleoside triphosphates. Agents such as deoxycytidine might be able to favourably modify the immunodeficient state by inhibiting deoxyribonucleoside phosphorylation. Deficiencies of other nucleotide catabolic enzymes, if selectively expressed by lymphocytes, might also lead to immunodeficiency via nucleoside trapping in lymphoid tissues. Purine deoxyribonucleoside analogues, either alone or in combination with ADA inhibitors, may have value as lymphospecific antimetabolites.Keywords
This publication has 20 references indexed in Scilit:
- Correlation of adenosine deaminase activity with cell surface markers in acute lymphoblastic leukemia.Journal of Clinical Investigation, 1978
- Deoxyguanosine toxicity in a mouse T lymphoma: Relationship to purine nucleoside phosphorylase-associated immune dysfunctionCell, 1978
- Deoxyguanosine Triphosphate as a Possible Toxic Metabolite in the Immunodeficiency Associated with Purine Nucleoside Phosphorylase DeficiencyJournal of Clinical Investigation, 1978
- Inhibition of maturation of human precursor lymphocytes by coformycin, and inhibitor of the enzyme adenosine deaminaseThe Journal of Experimental Medicine, 1976
- TRANSPORT OF NUCLEOSIDES*Annals of the New York Academy of Sciences, 1975
- NUCLEOSIDE-PHOSPHORYLASE DEFICIENCY IN A CHILD WITH SEVERELY DEFECTIVE T-CELL IMMUNITY AND NORMAL B-CELL IMMUNITYThe Lancet, 1975
- Workshop on severe combined immunological deficiency disease and adenosine deaminase deficiency: Albany, New York, on October 1, 1973Clinical Immunology and Immunopathology, 1974
- EPSTEIN-BARR VIRUS-NEGATIVE HUMAN MALIGNANT T-CELL LINESThe Journal of Experimental Medicine, 1974
- ADENOSINE-DEAMINASE DEFICIENCY IN TWO PATIENTS WITH SEVERELY IMPAIRED CELLULAR IMMUNITYThe Lancet, 1972
- Further studies on the effect of deoxyadenosine on the accumulation of deoxyadenosine triphosphate and inhibition of deoxyribonucleic acid synthesis in Ehrlich ascites tumor cells in vitroBiochimica et Biophysica Acta (BBA) - Specialized Section on Nucleic Acids and Related Subjects, 1962